rs527616: Understanding Genetic Associations with Breast Cancer
The genetic variant rs527616 is a single nucleotide polymorphism (SNP) located in an intergenic region on chromosome 18. It has been identified in various genome-wide association studies as being linked to an increased susceptibility to breast cancer and ductal carcinoma in situ (DCIS).
What each genotype means
Baseline risk profile
This genotype represents the most common genetic state at this location. Research indicates that individuals with this profile do not carry the specific genetic marker associated with an increased risk of ductal carcinoma in situ (DCIS) in younger patients.
This is the most frequent genotype observed across most global populations.
Increased risk marker
This genotype includes one copy of the variant associated with a higher statistical likelihood of developing ductal carcinoma in situ (DCIS) at a younger age. While this association is documented, it is important to remember that genetic risk is only one factor in overall health, and you should discuss your personal and family history with a healthcare provider.
This genotype is found at varying frequencies depending on ancestral background, appearing in a significant minority of the population.
Elevated risk marker
This genotype includes two copies of the variant associated with a higher statistical likelihood of developing ductal carcinoma in situ (DCIS) at a younger age. This finding suggests a moderate increase in risk compared to the general population, though it does not guarantee the development of any condition. Please consult with a clinician to discuss appropriate screening or risk-assessment strategies based on your full clinical profile.
This genotype is less common than the AA or AG profiles in most studied populations.
What is rs527616?
The variant rs527616 is a single nucleotide polymorphism, which is a variation at a single position in the DNA sequence. It is located on chromosome 18 at position 18q11.2. Because it is described as an intergenic variant, it does not sit within the protein-coding sequence of a known gene. Instead, it is situated in a region associated with the long non-coding RNA (lncRNA) AQP4-AS1. In genetics, intergenic variants are often studied to see if they influence the regulation of nearby genes or functional elements, even if they do not directly alter a protein's structure. Researchers use these markers to better understand the complex genetic architecture that may contribute to disease risk across different populations.
Research and Associations
The evidence linking rs527616 to breast cancer is considered moderate and has been observed in several studies. Research has specifically highlighted its association with ductal carcinoma in situ (DCIS), a non-invasive form of breast cancer, particularly in younger patients. Additionally, some studies have investigated its role in breast cancer susceptibility more broadly, including in specific populations such as those in southern Brazil. However, the biological mechanism remains a subject of ongoing investigation. Some researchers have suggested that other nearby variants, such as rs604702, might be in strong linkage disequilibrium with rs527616, meaning they are often inherited together. This makes it difficult for scientists to determine if rs527616 is the direct cause of the observed risk or if it is simply a marker for another nearby functional change.
Interpreting Genetic Risk
It is important to understand that having a specific genotype at the rs527616 locus does not mean an individual will develop breast cancer. Genetic predisposition is only one piece of a much larger puzzle that includes environmental factors, lifestyle, and other genetic markers. The associations found in genome-wide association studies are statistical, meaning they describe trends across large groups of people rather than predicting outcomes for a single person. Because the evidence is still evolving and the exact biological impact is not fully understood, this information should not be used for personal medical diagnosis. If you have concerns about your family history or personal risk for breast cancer, the most appropriate step is to consult with a healthcare professional or a genetic counselor who can provide context based on your complete clinical profile.
How common is this variant?
The frequency of the C and G alleles varies significantly across different ancestral populations. Studies often note that the C allele is less frequent than the G allele in certain cohorts, such as those analyzed in southern Brazil.
Frequently asked questions
Does having the rs527616 variant mean I will get breast cancer?
No. This variant is associated with a statistical increase in risk across large populations, but it is not a diagnostic tool. Many factors, including family history and lifestyle, play a much larger role in individual cancer risk.
What is an intergenic variant?
An intergenic variant is a genetic change located in the DNA between genes. While it does not code for a protein itself, it may still influence how nearby genes are turned on or off.
Should I get tested for rs527616?
Routine testing for this specific SNP is not currently recommended for clinical breast cancer screening. If you are concerned about your risk, speak with a doctor about established screening guidelines based on your age and family history.
What is linkage disequilibrium?
Linkage disequilibrium occurs when two or more genetic variants are inherited together more often than would be expected by chance. This can make it difficult for researchers to identify which specific variant is actually responsible for a disease association.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs527616?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant in the PD-1 gene is associated with susceptibility to various genitourinary cancers including prostate and renal cell carcinoma.
This common variant at 1p11.2 shows a stronger association with lobular breast cancer histology compared to ductal histology.
This variant shows borderline significance for association with celiac disease in the Dutch population.
The C allele of this variant is associated with an increased risk of chronic obstructive pulmonary disease (COPD) in the Chinese Han population.
This variant (p.Asn453Ser, formerly Val432Leu) in the CYP1B1 gene is associated with altered enzyme activity and has been investigated for susceptibility to various cancers, including breast and prostate cancer.
This variant is a pathogenic mutation in the MYH7 gene associated with hypertrophic cardiomyopathy.